CARDIOMID
0834.479.320 · rovalta.com · 24/09/2026
NORMAL SITUATION
CARDIOMID
Company — Normal situation.
Financial year 2023 · Closed on 31/12/2023
Net result-6,6 k €-110,7 %over 1 year
Gross margin-5,8 k €-109,2 %over 1 year
Equity-3,9 k €-242,2 %over 1 year
Overview
Identity
Source · BCE/KBOCARDIOMID is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0834.479.320
- Legal form
- Private company with limited liability
- Contributed capital
- 25 000,00 €
- Latest accounts
- 31/12/2023
Financials
Source · NBB, 13 filingsTrend over 13 financial years
| 2023 | 2022 | 2021 | 2020 | 2019 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -5,8 k € | -109% | 62,6 k € | +645% | -11,5 k € | -81.2% | -6,3 k € | -129% | 22,1 k € |
| EBITDA | -6,5 k € | -110% | 61,9 k € | +610% | -12,1 k € | -73.7% | -7 k € | -133% | 21,5 k € |
| Operating result | -6,5 k € | -110% | 61,9 k € | +610% | -12,1 k € | -73.7% | -7 k € | -133% | 21,5 k € |
| Net result | -6,6 k € | -111% | 61,9 k € | +607% | -12,2 k € | -73.7% | -7 k € | -133% | 21,3 k € |
| Balance sheet | |||||||||
| Equity | -3,9 k € | -242% | 2,7 k € | +105% | -59,2 k € | -26.0% | -47 k € | -17.6% | -39,9 k € |
| Total assets | 8,1 k € | -95.6% | 186 k € | +64.2% | 113,3 k € | +3.6% | 109,4 k € | -3.1% | 112,9 k € |
| Cash | 6,8 k € | -92.6% | 91,5 k € | -14.8% | 107,5 k € | +7.5% | 100 k € | +27.4% | 78,5 k € |
| Debts | 12 k € | -93.4% | 183,3 k € | +6.3% | 172,5 k € | +10.3% | 156,4 k € | +2.3% | 152,8 k € |
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Board of directors
Source · NBB, accounts to 31/12/20232 active · 20 ended
Active mandates
Carl Gustaaf Convens
ActiveStefan Lucien Verheye
ActiveEnded mandates
Carl Convens
EndedCarl Convens
EndedCarl Convens
EndedDIRK STOCKMAN
EndedFinancials
Full financial information
Source · NBB| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 |
| Closing of the financial year | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 27/03/2024 | 11/09/2023 | 30/08/2022 | 31/07/2021 | 30/10/2020 | 21/08/2019 |
| General meeting | 20/02/2024 | 30/05/2023 | 31/05/2022 | 25/05/2021 | 07/09/2020 | 28/05/2019 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 13 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2023 | 20/02/2024 | 27/03/2024 | Dutch | |
| Micro model | 31/12/2022 | 30/05/2023 | 11/09/2023 | Dutch | |
| Micro model | 31/12/2021 | 31/05/2022 | 30/08/2022 | Dutch | |
| Micro model | 31/12/2020 | 25/05/2021 | 31/07/2021 | Dutch | |
| Micro model | 31/12/2019 | 07/09/2020 | 30/10/2020 | Dutch | |
| Micro model | 31/12/2018 | 28/05/2019 | 21/08/2019 | Dutch | |
| Micro model | 31/12/2017 | 29/05/2018 | 28/08/2018 | Dutch | |
| Micro model | 31/12/2016 | 30/05/2017 | 17/08/2017 | Dutch | |
| Abridged model | 31/12/2015 | 31/05/2016 | 12/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 26/05/2015 | 12/08/2016 | Dutch | |
| Abridged model | 31/12/2013 | 27/05/2014 | 26/06/2014 | Dutch | |
| Abridged model | 31/12/2012 | 28/05/2013 | 11/09/2013 | Dutch | |
| Abridged model | 31/12/2011 | 29/05/2012 | 23/08/2012 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20232 active · 20 ended
Active mandates
Carl Gustaaf Convens
ActiveStefan Lucien Verheye
ActiveEnded mandates
Carl Convens
EndedCarl Convens
EndedCarl Convens
EndedDIRK STOCKMAN
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2023Annual accounts 2023-6,6 k €↓
- 2022Annual accounts 202261,9 k €↑
- 2021Annual accounts 2021-12,2 k €↓
- 2020Annual accounts 2020-7 k €↓
- 2019Annual accounts 201921,3 k €↓
- 2018Annual accounts 201821,7 k €↑
- 2017Annual accounts 2017-33 k €↓
- 2016Annual accounts 201624,8 k €↑
- 2015Annual accounts 2015-40,3 k €↑
- 2014Annual accounts 2014-42,1 k €↓
- 2013Annual accounts 20137,5 k €↑
- 2012Annual accounts 2012-71,8 k €↓
- 2011Annual accounts 201147 k €